Banner Witcoff attorney Sarah A. Kagan will explore the patentability of therapeutics and vaccines related to COVID-19 for the June 17 episode of The McCarthy Institute Series.
As part of the episode, Sarah will join The McCarthy Institute Director David Franklyn for a discussion on biotech patenting around COVID-19. The webinar will examine the patentability of COVID-related therapeutics and vaccines, as well as ethical and social justice implications of patenting in this space. Sarah and David, a professor of Llaw and business at Golden Gate University, will also discuss how to counsel biotech clients with regard to patentability issues related to COVID.
The live episode, which marks the second in the ongoing series, will take place at 3 p.m. ET on June 17. Click here to register or for more information on the free webinar series.
